ArticleApplied health economics and health policy2025

Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England.

Beth Woods et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.